世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

体外診断用ラテックス粒子の世界市場インサイト、2030年までの予測


Global Latex Particle for In-Vitro Diagnostics Market Insights, Forecast to 2030

体外診断用ラテックス粒子の世界市場は、2024年の5,102万米ドルから2030年には7,025万米ドルに成長し、予測期間中の年間平均成長率（CAGR）は5.48％と予測されている。 現在、IVD産業向けラテックス粒子の市場集... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2024年12月3日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

体外診断用ラテックス粒子の世界市場は、2024年の5,102万米ドルから2030年には7,025万米ドルに成長し、予測期間中の年間平均成長率（CAGR）は5.48％と予測されている。
現在、IVD産業向けラテックス粒子の市場集中度は、技術の壁が高いため比較的高い。主なプレーヤーはJSR Life Sciences、Merck、Bangs Laboratories、Thermo Fisher、VDO Biotechなどである。JSR Life Sciencesは最大手で、2023年の世界売上高シェアは47.55%である。

製品の種類別では、市場の主流はカルボキシ変性ラテックス粒子で、市場シェアの60％以上を占めている。製品の用途としては、ラテックス免疫比濁測定が最大の用途方向であり、50％以上を占めている。
消費については、北米、中国、欧州が主な消費地域で、2023年の世界総売上高の93.27%を累積で占めている。
生産面では、2019年から2024年まで、2030年までの予測で、体外診断用ラテックス粒子の生産量、成長率、メーカー別市場シェア、地域別市場シェア（地域レベル、国レベル）を調査している。
消費面では、本レポートでは、体外診断用ラテックス粒子の地域別（地域レベル、国レベル）、企業別、タイプ別、用途別の売上高に焦点を当て、2019年から2024年まで、そして2030年までの予測について調査しています。

レポートを含む：
体外診断用ラテックス粒子の世界市場の概要、生産能力、生産量、収益、価格を紹介します。2019年～2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
本レポートでは、体外診断用ラテックス粒子の主要生産者を調査し、主要地域・国の消費量も掲載しています。体外診断用ラテックスパーティクルの今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

このレポートでは、体外診断用ラテックス粒子の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界の体外診断用ラテックス粒子市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。体外診断用ラテックス粒子の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
JSR Life Sciences社、Merck社、Bangs Laboratories社、Thermo Fisher社、Agilent社、IKERLAT Polymers社、藤倉化成社、CD Bioparticles社、VDO Biotech社など、世界の主要企業の詳細な企業プロフィール。

市場区分

企業別
JSRライフサイエンス
メルク
バングス・ラボラトリーズ
サーモ・フィッシャー
アジレント
イケラトポリマー
藤倉化成
CDバイオ粒子
VDOバイオテック
蘇州ナノマイクロ
サンレジン新材料

タイプ別セグメント
プレーンラテックス粒子
カルボキシ変性ラテックス粒子
その他

用途別セグメント
ラテックス免疫比濁法
ラテックス凝集試験
イムノクロマト法
その他

地域別生産量
北米
欧州
中国
日本

地域別売上高
米国およびカナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
インド ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東、アフリカ、中南米
ブラジル
メキシコ
トルコ
GCC諸国

各章の概要
第1章：報告書のスコープ、各市場セグメント（タイプ別、用途別など）の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性についてハイレベルな見解を提供します。
第2章：世界および主要生産者（地域/国）の体外診断用ラテックス粒子の生産/生産量。各生産者の生産量、今後6年間の発展可能性を定量的に分析している。
第3章：体外診断用ラテックス粒子の世界、地域レベル、国レベルでの販売（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場空間を紹介する。
第4章：体外診断用ラテックス粒子メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第5章：タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントのブルーオーシャン市場を見つけるのに役立ちます。
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのに役立ちます。
第7章 北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。
第9章：中国：タイプ別、用途別、セグメント別の売上高と収益。
第10章：アジア（中国を除く）：タイプ別、アプリケーション別、地域別、セグメント別の売上高、収益。
第11章：中東、アフリカ、ラテンアメリカ：タイプ別、用途別、国別、セグメント別の売上高、収益。
第12章：主要メーカーのプロファイルを提供し、製品の説明と仕様、体外診断用ラテックス粒子の売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第13章：産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第14章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第15章：レポートの要点と結論。

ページTOPに戻る


目次

1 Study Coverage 1
1.1 Latex Particle for In-Vitro Diagnostics Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030 1
1.2.2 Plain Latex Particles 3
1.2.3 Carboxy-Modified Latex Particles 4
1.2.4 Other 4
1.3 Market by Application 4
1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030 5
1.3.2 Latex Immunoturbidimetry 7
1.3.3 Latex Agglutination Test 7
1.3.4 Immunochromatography 7
1.3.5 Other 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 Global Latex Particle for In-Vitro Diagnostics Production 11
2.1 Global Latex Particle for In-Vitro Diagnostics Production Capacity (2019-2030) 11
2.2 Global Latex Particle for In-Vitro Diagnostics Production by Region: 2019 VS 2023 VS 2030 12
2.3 Global Latex Particle for In-Vitro Diagnostics Production by Region 14
2.3.1 Global Latex Particle for In-Vitro Diagnostics Historic Production by Region (2019-2024) 14
2.3.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Production by Region (2025-2030) 14
2.3.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2030) 15
2.4 USA 16
2.5 Europe 17
2.6 China 18
2.7 Japan 19
3 Executive Summary 20
3.1 Global Latex Particle for In-Vitro Diagnostics Revenue Estimates and Forecasts 2019-2030 20
3.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region 21
3.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030 21
3.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024) 24
3.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030) 24
3.2.4 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2019-2030) 25
3.3 Global Latex Particle for In-Vitro Diagnostics Sales Estimates and Forecasts 2019-2030 26
3.4 Global Latex Particle for In-Vitro Diagnostics Sales by Region 26
3.4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Region: 2019 VS 2023 VS 2030 26
3.4.2 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2024) 28
3.4.3 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2025-2030) 28
3.4.4 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2019-2030) 29
3.5 US & Canada 30
3.6 Europe 32
3.7 China 34
3.8 Asia (excluding China) 36
3.9 Middle East, Africa and Latin America 38
4 Competition by Manufacturers 40
4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers 40
4.1.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers (2019-2024) 40
4.1.2 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Manufacturers (2019-2024) 41
4.1.3 Global Top 3 and Top 5 Largest Manufacturers of Latex Particle for In-Vitro Diagnostics in 2023 42
4.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers 43
4.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers (2019-2024) 43
4.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Manufacturers (2019-2024) 44
4.2.3 Global Top 3 and Top 5 Companies by Latex Particle for In-Vitro Diagnostics Revenue in 2023 46
4.3 Global Latex Particle for In-Vitro Diagnostics Sales Price by Manufacturers (2019-2024) 46
4.4 Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2022 VS 2023 47
4.5 Analysis of Competitive Landscape 48
4.5.1 Manufacturers Market Concentration Ratio (CR5) 48
4.5.2 Global Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 48
4.6 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Base Distribution and Headquarters 49
4.7 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offered and Application 50
4.8 Establish Date of Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics 51
4.9 Mergers & Acquisitions, Expansion Plans 52
5 Market Size by Type 53
5.1 Global Latex Particle for In-Vitro Diagnostics Sales by Type 53
5.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Type (2019-2024) 53
5.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Type (2025-2030) 53
5.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030) 54
5.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Type 55
5.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Type (2019-2024) 55
5.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Type (2025-2030) 55
5.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030) 56
5.3 Global Latex Particle for In-Vitro Diagnostics Price by Type 56
5.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Type (2019-2024) 56
5.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Type (2025-2030) 57
6 Market Size by Application 58
6.1 Global Latex Particle for In-Vitro Diagnostics Sales by Application 58
6.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Application (2019-2024) 58
6.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Application (2025-2030) 58
6.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030) 59
6.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Application 60
6.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Application (2019-2024) 60
6.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Application (2025-2030) 60
6.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030) 61
6.3 Global Latex Particle for In-Vitro Diagnostics Price by Application 62
6.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Application (2019-2024) 62
6.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Application (2025-2030) 62
7 US & Canada 63
7.1 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Type 63
7.1.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 63
7.1.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 64
7.2 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Application 66
7.2.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 66
7.2.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 67
7.3 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Country 69
7.3.1 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 69
7.3.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030) 69
7.3.3 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030) 71
7.3.4 US 73
7.3.5 Canada 74
8 Europe 75
8.1 Europe Latex Particle for In-Vitro Diagnostics Market Size by Type 75
8.1.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 75
8.1.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 76
8.2 Europe Latex Particle for In-Vitro Diagnostics Market Size by Application 78
8.2.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 78
8.2.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 79
8.3 Europe Latex Particle for In-Vitro Diagnostics Market Size by Country 81
8.3.1 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 81
8.3.2 Europe Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030) 81
8.3.3 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030) 83
8.3.4 Germany 84
8.3.5 France 85
8.3.6 U.K. 86
8.3.7 Italy 87
8.3.8 Russia 88
9 China 89
9.1 China Latex Particle for In-Vitro Diagnostics Market Size by Type 89
9.1.1 China Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 89
9.1.2 China Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 90
9.2 China Latex Particle for In-Vitro Diagnostics Market Size by Application 92
9.2.1 China Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 92
9.2.2 China Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 93
10 Asia (excluding China) 95
10.1 Asia Latex Particle for In-Vitro Diagnostics Market Size by Type 95
10.1.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 95
10.1.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 96
10.2 Asia Latex Particle for In-Vitro Diagnostics Market Size by Application 98
10.2.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 98
10.2.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 99
10.3 Asia Latex Particle for In-Vitro Diagnostics Market Size by Region 101
10.3.1 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030 101
10.3.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2030) 101
10.3.3 Asia Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2030) 103
10.3.4 Japan 104
10.3.5 South Korea 105
10.3.6 China Taiwan 106
10.3.7 Southeast Asia 107
10.3.8 India 108
11 Middle East, Africa and Latin America 109
11.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Type 109
11.1.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 109
11.1.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 110
11.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Application 112
11.2.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 112
11.2.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 113
11.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Country 115
11.3.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 115
11.3.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030) 115
11.3.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030) 117
11.3.4 Brazil 119
11.3.5 Mexico 120
11.3.6 Turkey 121
11.3.7 GCC Countries 122
12 Corporate Profile 123
12.1 JSR Life Sciences 123
12.1.1 JSR Life Sciences Corporation Information 123
12.1.2 JSR Life Sciences Overview 123
12.1.3 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 124
12.1.4 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 124
12.1.5 JSR Life Sciences Recent Developments 126
12.2 Merck 127
12.2.1 Merck Company Information 127
12.2.2 Merck Overview 127
12.2.3 Merck Latex Particle for In-Vitro Diagnostics Sales, Price, Revenue and Gross Margin (2019-2024) 128
12.2.4 Merck Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 128
12.2.5 Merck Recent Developments 133
12.3 Bangs Laboratories 134
12.3.1 Bangs Laboratories Corporation Information 134
12.3.2 Bangs Laboratories Overview 134
12.3.3 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 135
12.3.4 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 136
12.3.5 Bangs Laboratories Recent Developments 138
12.4 Thermo Fisher 139
12.4.1 Thermo Fisher Corporation Information 139
12.4.2 Thermo Fisher Overview 140
12.4.3 Thermo Fisher Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 140
12.4.4 Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 141
12.4.5 Thermo Fisher Recent Developments 144
12.5 Agilent 144
12.5.1 Agilent Corporation Information 144
12.5.2 Agilent Overview 145
12.5.3 Agilent Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 145
12.5.4 Agilent Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 146
12.5.5 Agilent Recent Developments 149
12.6 IKERLAT Polymers 150
12.6.1 IKERLAT Polymers Corporation Information 150
12.6.2 IKERLAT Polymers Overview 150
12.6.3 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 151
12.6.4 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 151
12.6.5 IKERLAT Polymers Recent Developments 156
12.7 Fujikura Kasei 157
12.7.1 Fujikura Kasei Corporation Information 157
12.7.2 Fujikura Kasei Overview 157
12.7.3 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 158
12.7.4 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 158
12.8 CD Bioparticles 159
12.8.1 CD Bioparticles Corporation Information 159
12.8.2 CD Bioparticles Overview 159
12.8.3 CD Bioparticles Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 160
12.8.4 CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 160
12.8.5 CD Bioparticles Recent Developments 166
12.9 VDO Biotech 167
12.9.1 VDO Biotech Corporation Information 167
12.9.2 VDO Biotech Overview 168
12.9.3 VDO Biotech Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 168
12.9.4 VDO Biotech Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 169
12.9.5 VDO Biotech Recent Developments 171
12.10 Suzhou NanoMicro 172
12.10.1 Suzhou NanoMicro Corporation Information 172
12.10.2 Suzhou NanoMicro Overview 172
12.10.3 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 173
12.10.4 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 173
12.10.5 Suzhou NanoMicro Recent Developments 174
12.11 Sunresin New Materials 175
12.11.1 Sunresin New Materials Corporation Information 175
12.11.2 Sunresin New Materials Overview 175
12.11.3 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 176
12.11.4 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 176
13 Industry Chain and Sales Channels Analysis 178
13.1 Latex Particle for In-Vitro Diagnostics Industry Chain Analysis 178
13.2 Latex Particle for In-Vitro Diagnostics Key Raw Materials 178
13.2.1 Key Raw Materials 178
13.2.2 Raw Materials Key Suppliers 179
13.3 Latex Particle for In-Vitro Diagnostics Production Mode & Process 179
13.4 Latex Particle for In-Vitro Diagnostics Sales and Marketing 180
13.4.1 Latex Particle for In-Vitro Diagnostics Sales Channels 180
13.4.2 Latex Particle for In-Vitro Diagnostics Distributors 180
13.5 Latex Particle for In-Vitro Diagnostics Customers 181
14 Latex Particle for In-Vitro Diagnostics Market Dynamics 182
14.1.1 Latex Particle for In-Vitro Diagnostics Industry Trends 182
14.1.2 Latex Particle for In-Vitro Diagnostics Market Drivers 183
14.1.3 Latex Particle for In-Vitro Diagnostics Market Challenges 184
14.1.4 Latex Particle for In-Vitro Diagnostics Market Restraints 185
15 Key Findings in the Global Latex Particle for In-Vitro Diagnostics Study 187
16 Appendix 188
16.1 Research Methodology 188
16.1.1 Methodology/Research Approach 188
16.1.2 Data Source 192
16.2 Author Details 195

　

ページTOPに戻る


　

Summary

The global Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 51.02 million in 2024 to US$ 70.25 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.48% during the forecast period.
At present, the market concentration of the latex particle for IVD industry is relatively high due to the high technology barrier. Key players include JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, VDO Biotech and so on. JSR Life Sciences is the largest player, accounting for 47.55% revenue share globally in 2023.

In terms of product types, the mainstream product on the market is carboxy-modified latex particles, which occupies more than 60% of the market share. As for product applications, latex immunoturbidimetry is the largest application direction, accounting for more than 50%.
For consumption, North America, China and Europe are the main consumption areas, cumulatively accounting for 93.27% of the global total sales in 2023.
In terms of production side, this report researches the Latex Particle for In-Vitro Diagnostics production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Latex Particle for In-Vitro Diagnostics by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Includes:
This report presents an overview of global market for Latex Particle for In-Vitro Diagnostics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Latex Particle for In-Vitro Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Latex Particle for In-Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latex Particle for In-Vitro Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Latex Particle for In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Latex Particle for In-Vitro Diagnostics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, and VDO Biotech, etc.

Market Segmentation

By Company
JSR Life Sciences
Merck
Bangs Laboratories
Thermo Fisher
Agilent
IKERLAT Polymers
Fujikura Kasei
CD Bioparticles
VDO Biotech
Suzhou NanoMicro
Sunresin New Materials

Segment by Type
Plain Latex Particles
Carboxy-Modified Latex Particles
Other

Segment by Application
Latex Immunoturbidimetry
Latex Agglutination Test
Immunochromatography
Other

Production by Region
North America
Europe
China
Japan

Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Latex Particle for In-Vitro Diagnostics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Latex Particle for In-Vitro Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latex Particle for In-Vitro Diagnostics sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage 1
1.1 Latex Particle for In-Vitro Diagnostics Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030 1
1.2.2 Plain Latex Particles 3
1.2.3 Carboxy-Modified Latex Particles 4
1.2.4 Other 4
1.3 Market by Application 4
1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030 5
1.3.2 Latex Immunoturbidimetry 7
1.3.3 Latex Agglutination Test 7
1.3.4 Immunochromatography 7
1.3.5 Other 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 Global Latex Particle for In-Vitro Diagnostics Production 11
2.1 Global Latex Particle for In-Vitro Diagnostics Production Capacity (2019-2030) 11
2.2 Global Latex Particle for In-Vitro Diagnostics Production by Region: 2019 VS 2023 VS 2030 12
2.3 Global Latex Particle for In-Vitro Diagnostics Production by Region 14
2.3.1 Global Latex Particle for In-Vitro Diagnostics Historic Production by Region (2019-2024) 14
2.3.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Production by Region (2025-2030) 14
2.3.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2030) 15
2.4 USA 16
2.5 Europe 17
2.6 China 18
2.7 Japan 19
3 Executive Summary 20
3.1 Global Latex Particle for In-Vitro Diagnostics Revenue Estimates and Forecasts 2019-2030 20
3.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region 21
3.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030 21
3.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024) 24
3.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030) 24
3.2.4 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2019-2030) 25
3.3 Global Latex Particle for In-Vitro Diagnostics Sales Estimates and Forecasts 2019-2030 26
3.4 Global Latex Particle for In-Vitro Diagnostics Sales by Region 26
3.4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Region: 2019 VS 2023 VS 2030 26
3.4.2 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2024) 28
3.4.3 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2025-2030) 28
3.4.4 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2019-2030) 29
3.5 US & Canada 30
3.6 Europe 32
3.7 China 34
3.8 Asia (excluding China) 36
3.9 Middle East, Africa and Latin America 38
4 Competition by Manufacturers 40
4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers 40
4.1.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers (2019-2024) 40
4.1.2 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Manufacturers (2019-2024) 41
4.1.3 Global Top 3 and Top 5 Largest Manufacturers of Latex Particle for In-Vitro Diagnostics in 2023 42
4.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers 43
4.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers (2019-2024) 43
4.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Manufacturers (2019-2024) 44
4.2.3 Global Top 3 and Top 5 Companies by Latex Particle for In-Vitro Diagnostics Revenue in 2023 46
4.3 Global Latex Particle for In-Vitro Diagnostics Sales Price by Manufacturers (2019-2024) 46
4.4 Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2022 VS 2023 47
4.5 Analysis of Competitive Landscape 48
4.5.1 Manufacturers Market Concentration Ratio (CR5) 48
4.5.2 Global Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 48
4.6 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Base Distribution and Headquarters 49
4.7 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offered and Application 50
4.8 Establish Date of Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics 51
4.9 Mergers & Acquisitions, Expansion Plans 52
5 Market Size by Type 53
5.1 Global Latex Particle for In-Vitro Diagnostics Sales by Type 53
5.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Type (2019-2024) 53
5.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Type (2025-2030) 53
5.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030) 54
5.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Type 55
5.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Type (2019-2024) 55
5.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Type (2025-2030) 55
5.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030) 56
5.3 Global Latex Particle for In-Vitro Diagnostics Price by Type 56
5.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Type (2019-2024) 56
5.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Type (2025-2030) 57
6 Market Size by Application 58
6.1 Global Latex Particle for In-Vitro Diagnostics Sales by Application 58
6.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Application (2019-2024) 58
6.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Application (2025-2030) 58
6.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030) 59
6.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Application 60
6.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Application (2019-2024) 60
6.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Application (2025-2030) 60
6.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030) 61
6.3 Global Latex Particle for In-Vitro Diagnostics Price by Application 62
6.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Application (2019-2024) 62
6.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Application (2025-2030) 62
7 US & Canada 63
7.1 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Type 63
7.1.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 63
7.1.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 64
7.2 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Application 66
7.2.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 66
7.2.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 67
7.3 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Country 69
7.3.1 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 69
7.3.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030) 69
7.3.3 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030) 71
7.3.4 US 73
7.3.5 Canada 74
8 Europe 75
8.1 Europe Latex Particle for In-Vitro Diagnostics Market Size by Type 75
8.1.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 75
8.1.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 76
8.2 Europe Latex Particle for In-Vitro Diagnostics Market Size by Application 78
8.2.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 78
8.2.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 79
8.3 Europe Latex Particle for In-Vitro Diagnostics Market Size by Country 81
8.3.1 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 81
8.3.2 Europe Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030) 81
8.3.3 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030) 83
8.3.4 Germany 84
8.3.5 France 85
8.3.6 U.K. 86
8.3.7 Italy 87
8.3.8 Russia 88
9 China 89
9.1 China Latex Particle for In-Vitro Diagnostics Market Size by Type 89
9.1.1 China Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 89
9.1.2 China Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 90
9.2 China Latex Particle for In-Vitro Diagnostics Market Size by Application 92
9.2.1 China Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 92
9.2.2 China Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 93
10 Asia (excluding China) 95
10.1 Asia Latex Particle for In-Vitro Diagnostics Market Size by Type 95
10.1.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 95
10.1.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 96
10.2 Asia Latex Particle for In-Vitro Diagnostics Market Size by Application 98
10.2.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 98
10.2.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 99
10.3 Asia Latex Particle for In-Vitro Diagnostics Market Size by Region 101
10.3.1 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030 101
10.3.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2030) 101
10.3.3 Asia Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2030) 103
10.3.4 Japan 104
10.3.5 South Korea 105
10.3.6 China Taiwan 106
10.3.7 Southeast Asia 107
10.3.8 India 108
11 Middle East, Africa and Latin America 109
11.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Type 109
11.1.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030) 109
11.1.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030) 110
11.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Application 112
11.2.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030) 112
11.2.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030) 113
11.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Country 115
11.3.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 115
11.3.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030) 115
11.3.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030) 117
11.3.4 Brazil 119
11.3.5 Mexico 120
11.3.6 Turkey 121
11.3.7 GCC Countries 122
12 Corporate Profile 123
12.1 JSR Life Sciences 123
12.1.1 JSR Life Sciences Corporation Information 123
12.1.2 JSR Life Sciences Overview 123
12.1.3 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 124
12.1.4 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 124
12.1.5 JSR Life Sciences Recent Developments 126
12.2 Merck 127
12.2.1 Merck Company Information 127
12.2.2 Merck Overview 127
12.2.3 Merck Latex Particle for In-Vitro Diagnostics Sales, Price, Revenue and Gross Margin (2019-2024) 128
12.2.4 Merck Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 128
12.2.5 Merck Recent Developments 133
12.3 Bangs Laboratories 134
12.3.1 Bangs Laboratories Corporation Information 134
12.3.2 Bangs Laboratories Overview 134
12.3.3 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 135
12.3.4 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 136
12.3.5 Bangs Laboratories Recent Developments 138
12.4 Thermo Fisher 139
12.4.1 Thermo Fisher Corporation Information 139
12.4.2 Thermo Fisher Overview 140
12.4.3 Thermo Fisher Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 140
12.4.4 Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 141
12.4.5 Thermo Fisher Recent Developments 144
12.5 Agilent 144
12.5.1 Agilent Corporation Information 144
12.5.2 Agilent Overview 145
12.5.3 Agilent Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 145
12.5.4 Agilent Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 146
12.5.5 Agilent Recent Developments 149
12.6 IKERLAT Polymers 150
12.6.1 IKERLAT Polymers Corporation Information 150
12.6.2 IKERLAT Polymers Overview 150
12.6.3 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 151
12.6.4 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 151
12.6.5 IKERLAT Polymers Recent Developments 156
12.7 Fujikura Kasei 157
12.7.1 Fujikura Kasei Corporation Information 157
12.7.2 Fujikura Kasei Overview 157
12.7.3 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 158
12.7.4 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 158
12.8 CD Bioparticles 159
12.8.1 CD Bioparticles Corporation Information 159
12.8.2 CD Bioparticles Overview 159
12.8.3 CD Bioparticles Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 160
12.8.4 CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 160
12.8.5 CD Bioparticles Recent Developments 166
12.9 VDO Biotech 167
12.9.1 VDO Biotech Corporation Information 167
12.9.2 VDO Biotech Overview 168
12.9.3 VDO Biotech Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 168
12.9.4 VDO Biotech Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 169
12.9.5 VDO Biotech Recent Developments 171
12.10 Suzhou NanoMicro 172
12.10.1 Suzhou NanoMicro Corporation Information 172
12.10.2 Suzhou NanoMicro Overview 172
12.10.3 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 173
12.10.4 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 173
12.10.5 Suzhou NanoMicro Recent Developments 174
12.11 Sunresin New Materials 175
12.11.1 Sunresin New Materials Corporation Information 175
12.11.2 Sunresin New Materials Overview 175
12.11.3 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024) 176
12.11.4 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications 176
13 Industry Chain and Sales Channels Analysis 178
13.1 Latex Particle for In-Vitro Diagnostics Industry Chain Analysis 178
13.2 Latex Particle for In-Vitro Diagnostics Key Raw Materials 178
13.2.1 Key Raw Materials 178
13.2.2 Raw Materials Key Suppliers 179
13.3 Latex Particle for In-Vitro Diagnostics Production Mode & Process 179
13.4 Latex Particle for In-Vitro Diagnostics Sales and Marketing 180
13.4.1 Latex Particle for In-Vitro Diagnostics Sales Channels 180
13.4.2 Latex Particle for In-Vitro Diagnostics Distributors 180
13.5 Latex Particle for In-Vitro Diagnostics Customers 181
14 Latex Particle for In-Vitro Diagnostics Market Dynamics 182
14.1.1 Latex Particle for In-Vitro Diagnostics Industry Trends 182
14.1.2 Latex Particle for In-Vitro Diagnostics Market Drivers 183
14.1.3 Latex Particle for In-Vitro Diagnostics Market Challenges 184
14.1.4 Latex Particle for In-Vitro Diagnostics Market Restraints 185
15 Key Findings in the Global Latex Particle for In-Vitro Diagnostics Study 187
16 Appendix 188
16.1 Research Methodology 188
16.1.1 Methodology/Research Approach 188
16.1.2 Data Source 192
16.2 Author Details 195

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（ケミカル）の最新刊レポート

QYResearch社の化学・材料分野での最新刊レポート

本レポートと同じKEY WORD（diagnostics）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/04　10:27

150.82 円

158.84 円

193.81 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.